American Skin Association (ASA) named Indian-origin dermatologist Anand Ganesan as the recipient of the 2023 Research Achievement Award at the International Societies for Investigative Dermatology (ISID) in Tokyo, Japan.
ASA's Research Achievement Awards recognizes those who have greatly advanced work related to autoimmunity and inflammation skin disorders, skin cancer and melanoma, psoriasis, vitiligo, and pigment cell disorders, public policy and medical education, discovery, and translational research, according to a release.
Ganesan was honored with the Research Achievement Award for his remarkable work in vitiligo and pigment cell disorders. He is presently a professor and vice chair for research at the Dermatology School of Medicine and Biological Chemistry at the University of California, Irvine.
Recognized as ‘America’s Best Doctors’ in 2010 he was appointed as the associate dean for physician-scientist development at the School of Medicine in 2022. According to his profile, he runs a research lab named Ganesan Lab, which works on interdisciplinary approaches to understand how melanocyte homeostasis is maintained in the skin.
Born in Parkridge, Illinois, Ganesan moved to Southern California at a young age. He obtained his medical degree from the University of California, Berkeley. As a medical professional, he maintains an active clinical practice focusing on patients with pigmentary disorders and skin cancer. He is working to develop new therapies to treat melanoma and pigmentary disorders, his profile revealed.
ASA is a unique collaboration of patients, families, advocates, physicians, and scientists association that has evolved over thirty-six years as a leading force in efforts to defeat melanoma, vitiligo, psoriasis, atopic dermatitis, and other skin diseases.
